Syra Health Corp. Elects New Directors, Appoints COO
Ticker: SYRA · Form: 8-K · Filed: Jun 17, 2025 · CIK: 1922335
| Field | Detail |
|---|---|
| Company | Syra Health Corp (SYRA) |
| Form Type | 8-K |
| Filed Date | Jun 17, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-appointment
TL;DR
Syra Health adds new blood to the board and names a new COO.
AI Summary
Syra Health Corp. announced on June 13, 2025, changes in its board of directors and executive compensation. Specifically, the company elected two new directors, Dr. David E. Johnson and Ms. Jennifer L. Johnson, and appointed Ms. Jennifer L. Johnson as Chief Operating Officer. The filing also details compensatory arrangements for certain officers.
Why It Matters
Changes in board composition and executive appointments can signal shifts in company strategy and leadership, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: medium — Changes in directorship and executive roles can introduce uncertainty regarding future strategy and operational execution.
Key Players & Entities
- Syra Health Corp. (company) — Registrant
- Dr. David E. Johnson (person) — Newly Elected Director
- Ms. Jennifer L. Johnson (person) — Newly Elected Director and Chief Operating Officer
- June 13, 2025 (date) — Date of earliest event reported
FAQ
Who are the newly elected directors of Syra Health Corp.?
The newly elected directors are Dr. David E. Johnson and Ms. Jennifer L. Johnson.
What is Ms. Jennifer L. Johnson's new role at Syra Health Corp.?
Ms. Jennifer L. Johnson has been appointed as the Chief Operating Officer.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 13, 2025.
What items are covered in this Form 8-K filing?
This filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
What is the principal executive office address for Syra Health Corp.?
The principal executive office address is 1119 Keystone Way N. #201, Carmel, IN 46032.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 17, 2025 by Dr. David E. Johnson regarding Syra Health Corp (SYRA).